Healing & Regeneration Peptides
Research peptides for tissue repair, wound healing and systemic regeneration processes. At the centre stand BPC-157 (Body Protection Compound) and TB-500 (Thymosin Beta-4), the two most-cited compounds in preclinical models of tendon, muscle and gastric barrier repair, alongside the popular Wolverine stack combining both. In addition, the copper tripeptide GHK-Cu for skin regeneration models and KPV as a short tripeptide fragment of Alpha-MSH. All peptides are Janoshik lab-tested, with batch-specific CoA on the product page.
All products
Related research
April 17, 2026
BPC-157 IV Pilot Study 2025: The First Published Human Safety Data
First human IV safety trial of BPC-157 (Lee and Burgess 2025, n=2): Zero adverse effects up to 20 mg on cardiac, hepatic, renal, and thyroid biomarkers.
Read more →
April 17, 2026
LL-37: What Researchers Need to Know About the Human Cathelicidin Peptide
Research overview of LL-37, the human cathelicidin: origin, mechanisms, wound healing and antimicrobial RCT data, reconstitution notes, and EU shipping.
Read more →
April 11, 2026
How to Buy Research Peptides in the EU: Payment Options Guide 2026
A practical guide to payment methods when buying research peptides in Europe. Compare credit card, SEPA and crypto options.
Read more →